Darren Charlton Smith, CFO of Telix Pharmaceuticals, exercised 1,111 share rights into shares at no cost, increasing his holdings to 11,921 ordinary shares, with no derivatives remaining.

NodeGuardian

2026-04-15 03:27:51

Abstract generation in progress

Telix Pharmaceuticals Ltd Group Chief Financial Officer Darren Charlton Smith exercised 1,111 share rights into 1,111 ordinary shares at an exercise price of $0.00 per share on March 29, 2026. These share rights, granted on January 1, 2025, vested on March 5, 2026. Following this compensation-related transaction, Smith directly holds 11,921 ordinary shares, with no remaining derivative balance.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
WCTCTradingChallengeShare8MUSDT
670.23K Popularity
#
GateMarchTransparencyReport
30.4K Popularity
#
GoldmanSachsFilesBitcoinIncomeETF
766.51K Popularity
#
USBlocksStraitofHormuz
738.6K Popularity
#
Gate13thAnniversary
182.47K Popularity

Sitemap

[Form 4] Telix Pharmaceuticals Ltd Insider Trading Activity

Trending Topics

WCTCTradingChallengeShare8MUSDT

GateMarchTransparencyReport

GoldmanSachsFilesBitcoinIncomeETF

USBlocksStraitofHormuz

Gate13thAnniversary

Pin